In addition to being a distinguished scientist with expertise in neurology, molecular genetics and biochemistry, Eric is an entrepreneur who has developed important drugs now in various stages of FDA approval process and has started drug companies (ReveraGen, BioPharma, and Agada BioSciences)—is CEO of one, as well as being Associate Dean for Research at Binghamton University’s new School of Pharmacy and Pharmaceutical Sciences. Eric is an important member of Cornell's Taskforce on Plants and Medicinal Science for students interested in both plants and various aspects of human health—one that would provide alternative entry into the health professions.
